What its about Partners Group has been a leading innovator of client solutions for the Private Wealth segment. In this segment Partner Group caters via wholesale/distribution sales channels to private wealth clients. The firm has been
HR Project Manager Department: Group HR – Baar We are seeking a highly motivated Project Manager to join our Group Human Resources team. This role is ideal for someone who can think strategically to scope and
Company Description Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing.
Global Marketing Director, Oncology Location: Zug - Switzerland, GSK HQ - London or Upper Providence - USA GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion
Company Description Sika is a specialty chemicals company with a globally leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing, and protection in the building sector and industrial manufacturing.
At Chain IQ, your ideas move fast. Chain IQ is a global AI‑driven procurement service partner headquartered in Baar, Switzerland, with operations across 16 offices worldwide. We are looking for a Senior Consultant in Procurement Operations &
Support the team across open-ended and closed-ended funds in day-to-day tasks Create tailored, persuasive and high-quality marketing materials and responses to client requests Assist with client queries and performance updates Serve as a point of contact with
The Business Management Assistant will support IO Legal Team, members of the MT of the Investment Office and the CIO.The role provides paralegal and legal-ad Audit - Senior Associate/Assistant Manager - Private Equity/Asset Management.In our Audit -
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines,